ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 526417 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 526417; 2) Community: the network communities that were significantly associated with the response to NSC 526417; 3) Molecule: the relationships between components within communities and NSC 526417; 4) MDR: the compounds that were significantly associated with the NSC 526417.

NSC Compound Enrichment Correlation
NSC 107043 Null 0.0267520285931239 -0.057817972
NSC 120925 Null 0.0267520285931239 0.39910774
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0267520285931239 0.66513845
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0267520285931239 0.03814269
NSC 330507 Tanespimycin 0.0267520285931239 0.25202038
NSC 58574 Pyrimidine, 2,4,5-trichloro-6-propyl- 0.0267520285931239 0.14181548
NSC 608984 Leucinostatine D 0.0267520285931239 0.48977516
NSC 632573 Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) 0.0267520285931239 0.17721697
NSC 63839 Triacryloylhexahydro-s-triazine 0.0267520285931239 0.12204261
NSC 641055 Null 0.0267520285931239 0.24151121
Total:86  Current:47    [First] [Prev] [Next] [Last]